Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Protective Effects of Akkermansia muciniphila on Intestinal Barrier Function and Inflammation
FY 2018-19
Summary
The gastrointestinal (GI) tract is inhabited by trillions of microorganisms that play a crucial role in digesting food, protecting the gut from harmful bacteria and developing the immune system. These microorganisms are also implicated in various GI disorders including inflammatory bowel disease (IBD). According to the Crohn’s and Colitis Foundation of Canada, the prevalence of IBD in Canada is one of the highest in the world and over 270,000 Canadians deal with these lifelong conditions for which there is currently no cure. Akkermansia muciniphila is a bacterium that accounts for approximately 3% of fecal microbes and has been shown to stimulate intestinal mucus production and strengthen the GI barrier. Studies have illustrated that lower levels of A. muciniphila are associated with higher levels of inflammation suggesting that A. muciniphila may have anti-inflammatory effects. Though several studies have linked IBD to decreased levels of A. muciniphila, the precise role and mechanism of A. muciniphila in the initiation and progression of IBD is yet to be determined. Based on recent findings, we believe A. muciniphila provides protective effects on intestinal inflammation by strengthening the epithelial barrier of the gut. Thus, the aim of this research study is to investigate the role and mechanism of A. muciniphila in intestinal inflammation and its protective effects on the gut barrier. This research has the potential to enhance the understanding of the development of IBD and the role that microbes play in intestinal inflammation. In addition, this research has the potential to lead to the development of new treatments by utilizing A. muciniphila to alleviate the symptoms experienced with IBD.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406404
Name
Grondin Jensine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Protective Effects of Akkermansia muciniphila on Intestinal Barrier Function and Inflammation
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Akkermansia Muciniphila; Inflammation; Inflammatory Bowel Disease; Microbiota
Abstract
The gastrointestinal (GI) tract is inhabited by trillions of microorganisms that play a crucial role in digesting food, protecting the gut from harmful bacteria and developing the immune system. These microorganisms are also implicated in various GI disorders including inflammatory bowel disease (IBD). According to the Crohn’s and Colitis Foundation of Canada, the prevalence of IBD in Canada is one of the highest in the world and over 270,000 Canadians deal with these lifelong conditions for which there is currently no cure. Akkermansia muciniphila is a bacterium that accounts for approximately 3% of fecal microbes and has been shown to stimulate intestinal mucus production and strengthen the GI barrier. Studies have illustrated that lower levels of A. muciniphila are associated with higher levels of inflammation suggesting that A. muciniphila may have anti-inflammatory effects. Though several studies have linked IBD to decreased levels of A. muciniphila, the precise role and mechanism of A. muciniphila in the initiation and progression of IBD is yet to be determined. Based on recent findings, we believe A. muciniphila provides protective effects on intestinal inflammation by strengthening the epithelial barrier of the gut. Thus, the aim of this research study is to investigate the role and mechanism of A. muciniphila in intestinal inflammation and its protective effects on the gut barrier. This research has the potential to enhance the understanding of the development of IBD and the role that microbes play in intestinal inflammation. In addition, this research has the potential to lead to the development of new treatments by utilizing A. muciniphila to alleviate the symptoms experienced with IBD.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grondin, Jensine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~